Published in Medical Imaging Law Weekly, August 2nd, 2005
Study 1: Aldosterone improves hepatic hemodynamics, but it improves neither left ventricular diastolic dysfunction nor exerts sympathoinhibitory effects.
"The present study was designed to determine the effects of long-term antialdosterone treatment on cardiac structural and functional alterations, portal and systemic hemodynamic as well as adrenergic dysfunction characterizing Child A cirrhotic patients with F1 esophageal varices," reported M. Pozzi and associates at the University Milano-Bicocca in Italy.
The researchers explained, "Twenty-two Child A...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Imaging Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.